Novira Therapeutics, Inc. — Form D
Novira Therapeutics, Inc. of RADNOR, PA, a company, filed a Form D exempt-offering notice with the SEC on 2012-08-23. The offering totals $26.5M, of which $11.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-08-23
- Form: D
- Accession: 0001556754-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $26.5M
- Amount sold: $11.0M
- Remaining: $15.5M
- Minimum investment: $58K
- Investors: 8
- Security types: equity
- Revenue range: Decline to Disclose
Issuer
- Name: Novira Therapeutics, Inc.
- CIK: 0001556754
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 259 N. RADNOR-CHESTER ROAD, SUITE 220, RADNOR, PA, 19087
- Phone: 215-260-7276
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Tim Shannon | Director | Westport, CT |
| Scott Rocklage | Director | Menlo Park, CA |
| Scott M Rocklage | Director | San Diego, CA |
| Daniel E Geffken | Executive Officer | San Diego, CA |
| Tim M Shannon | Director | Westport, CT |
| Christian S Schade | Director | Doylestown, PA |
| Christian S Schade | Executive Officer | Doylestown, PA |
| Nathaniel M Brown | Executive Officer | Doylestown, PA |
| Anthony M Ford-Hutchinson | Director | Doylestown, PA |
| Gianni M Gromo | Director | San Francisco, CA |
| Osvaldo S Flores | Executive Officer | Doylestown, PA |
| George M Hartman | Executive Officer | Doylestown, PA |
| Klaus M Klumpp | Executive Officer | Doylestown, PA |
| Douglas S Carr | Executive Officer | Doylestown, PA |
| Anthony Ford-Hutchinson | Director | Radnor, PA |
| Osvaldo Flores | Director | Radnor, PA |
| Osvaldo Flores | Executive Officer | Radnor, PA |
| George Hartman | Executive Officer | Radnor, PA |
| Gregory E Korbel | Executive Officer | Doylestown, PA |
| Gianni Gromo | Director | Menlo Park, CA |
Other filings by this issuer (2)
More